Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Autor: | Wahba, A, Vonk, A, Bidstrup, B |
---|---|
Zdroj: | Interactive Cardiovascular and Thoracic Surgery; February 2011, Vol. 12 Issue: 2 p139-140, 2p |
Databáze: | Supplemental Index |
Externí odkaz: |